Oxomemazine Sandoz (Oxomemazine)

Oxomemazine works by competitively inhibiting H1 histamine receptors in peripheral tissues and the central nervous system. This prevents histamine‑induced vasodilation, increased vascular permeability and sensory nerve activation, thereby diminishing the classic signs of an allergic response and producing a mild sedative effect.

The dosage of Oxomemazine Sandoz is determined by the prescribing clinician based on the patient’s age, weight, severity of symptoms and renal or hepatic function. The prescriber will select an appropriate strength and dosing schedule according to current clinical guidelines.

Safety data for oxomemazine in pregnancy are limited, so it should only be used if the potential benefit justifies any potential risk to the fetus. During breastfeeding, caution is advised because the drug may be excreted in breast milk; a healthcare professional should evaluate the risk‑benefit ratio.

To order Oxomemazine Sandoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Oxomemazine is a first‑generation H1‑antagonist, which provides effective symptom relief but is associated with more sedation than second‑generation antihistamines such as cetirizine or loratadine. Its sedative properties can be advantageous for patients needing nighttime symptom control, while newer agents may be preferred when minimal drowsiness is required.

Oxomemazine Sandoz tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect the product from moisture, direct sunlight and excessive heat to maintain its stability and potency throughout its shelf life.

Oxomemazine Sandoz is administered orally as a tablet, taken with or without food according to the prescriber’s instructions. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically directed by a healthcare professional.

Serious risks, though rare, include cardiac arrhythmias, severe allergic reactions such as anaphylaxis, hepatotoxicity, extrapyramidal symptoms and significant hematologic abnormalities. Patients should seek immediate medical attention if they experience symptoms like irregular heartbeat, swelling of the face or throat, jaundice, uncontrolled muscle movements or unexplained bruising.

Oxomemazine is contraindicated in individuals with known hypersensitivity to the drug or any other first‑generation antihistamines. It should also be avoided in patients taking mono‑amine oxidase inhibitors, those with severe hepatic impairment, and anyone for whom sedation poses a safety concern, such as operators of heavy machinery.